Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson’s Disease

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Genetic screens in human cells using the CRISPR-Cas9 system

Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856 · see citing works

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · see citing works

Protein detection using proximity-dependent DNA ligation assays

Fredriksson, S., Gullberg, M. T., Jarvius, J., Olsson, C., Pietras, K., Gustafsdottir, S., Östman, A., & Landegren, U. D. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-473 · Cited by 1,511 · see citing works

In vivo demonstration that α-synuclein oligomers are toxic

Winner, B., Jappelli, R., Maji, S. K., Desplats, P., Boyer, L. F., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,487 · see citing works

Structure and Dynamics of Micelle-bound Human α-Synuclein

Ulmer, T. S., Bax, A., Cole, N. B., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411805200 · Cited by 966 · see citing works

Structural disorder of monomeric α-synuclein persists in mammalian cells

Theillet, F., Binolfi, A., Bekei, B., Martorana, A., Rose, H. M., Stuiver, M., Verzini, S., Lorenz, D., van Rossum, M., Goldfarb, D., et al. (2016) · Nature · doi:10.1038/nature16531 · Cited by 877 · see citing works

Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation

Narhi, L. O., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F. H., Sitney, K. C., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710 · see citing works

The helix-turn-helix DNA binding motif

Brennan, R. G., & Matthews, B. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94115-3 · Cited by 618 · see citing works

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

Sofic, E., Lange, K. W., Jellinger, K. A., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 591 · see citing works

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Kontopoulos, E., Parvin, J. D., & Feany, M. Β. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 539 · see citing works

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537 · see citing works

Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

Gao, H., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 435 · see citing works

Nuclear Localization of α-Synuclein and Its Interaction with Histones

Goers, J. W. F., Manning-Bog, A., McCormack, A. L., Millett, I. S., Doniach, S., Monte, D. A. D., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi0341152 · Cited by 338 · see citing works

Ferroptosis and cell death mechanisms in Parkinson's disease

Guiney, S. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.004 · Cited by 337 · see citing works

Copper pathology in vulnerable brain regions in Parkinson's disease

Davies, K. M., Bohic, S., Carmona, A., Ortega, R., Cottam, V., Hare, D. J., Finberg, J. P. M., Reyes, S., Halliday, G. M., Mercer, J. F. B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.034 · Cited by 244 · see citing works

NPDock: a web server for protein–nucleic acid docking

Tuszyńska, I., Magnus, M., Jonak, K., Dawson, W., & Bujnicki, J. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv493 · Cited by 243 · see citing works

Alpha-Synuclein Function and Dysfunction on Cellular Membranes

Snead, D., & Eliezer, D. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.292 · Cited by 222 · see citing works

In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells

Dettmer, U., Newman, A. J., Luth, E. S., Bartels, T., & Selkoe, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403311 · Cited by 221 · see citing works

Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson’s disease

Siddiqui, A., Chinta, S. J., Mallajosyula, J. K., Rajagopolan, S., Hanson, I. M., Rane, A., Melov, S., & Andersen, J. K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.024 · Cited by 182 · see citing works

Improved Immunodetection of Endogenous α-Synuclein

Lee, B. R., & Kamitani, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023939 · Cited by 155 · see citing works

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau

Rousseaux, M. W. C., de Haro, M., Lasagna‐Reeves, C. A., Maio, A. D., Park, J., Jafar‐Nejad, P., Al‐Ramahi, I., Sharma, A., See, L., Lü, N., et al. (2016) · eLife · doi:10.7554/elife.19809 · Cited by 150 · see citing works

Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology

Rhinn, H., Qiang, L., Yamashita, T., Rhee, D. B., Zolin, A., Vanti, W. B., & Abeliovich, A. (2012) · Nature Communications · doi:10.1038/ncomms2032 · Cited by 142 · see citing works

Semi-quantitative analysis of α-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C-terminal specific monoclonal antibody

Zhang, L., Zhang, C., Zhu, Y., Cai, Q., Chan, P., Uéda, K., Yu, S., & Yang, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.067 · Cited by 130 · see citing works

Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1

Sengupta, S., Mantha, A. K., MITRA, S. P., & Bhakat, K. K. (2010) · Oncogene · doi:10.1038/onc.2010.435 · Cited by 120 · see citing works

Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil

Pandey, A., Vishnoi, K., Mahata, S., Tripathi, S. C., Misra, S. P., Misra, V., Mehrotra, R., Dwivedi, M., & Bharti, A. C. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1085581 · Cited by 120 · see citing works

Binding of α-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes

Peng, Y., Wang, C., Xu, H. H., Liu, Y., & Zhou, F. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.11.005 · Cited by 118 · see citing works

Metal-catalyzed Oxidation of α-Synuclein

Cole, N. B., Murphy, D. D., Lebowitz, J., Noto, L. D., Levine, R. L., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409946200 · Cited by 117 · see citing works

[5] Terminal transferase: Use in the tailing of DNA and for in Vitro mutagenesis

Deng, G., & Wu, R. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)00047-6 · Cited by 115 · see citing works

Copper- and iron-induced differential fibril formation in α-synuclein: TEM study

..., B., Indi, S. S., & Rao, K. S. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.052 · Cited by 110 · see citing works

Prereplicative repair of oxidized bases in the human genome is mediated by NEIL1 DNA glycosylase together with replication proteins

Hegde, M. L., Hegde, P. M., Bellot, L. J., Mandal, S. M., Hazra, T. K., Li, G., Boldogh, I. R., Tomkinson, A. E., & MITRA, S. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304231110 · Cited by 105 · see citing works

Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites

Binolfi, A., Limatola, A., Verzini, S., Kosten, J., Theillet, F., Rose, H. M., Bekei, B., Stuiver, M., van Rossum, M., & Selenko, P. (2016) · Nature Communications · doi:10.1038/ncomms10251 · Cited by 105 · see citing works

Deferoxamine Attenuates Iron-Induced Oxidative Stress and Prevents Mitochondrial Aggregation and α-Synuclein Translocation in SK-N-SH Cells in Culture

Sangchot, P., Sharma, S., Chetsawang, B., Porter, J. E., Govitrapong, P., & Ebadi, M. (2002) · Developmental Neuroscience · doi:10.1159/000065700 · Cited by 97 · see citing works

Mechanism of copper(II)-induced misfolding of Parkinson's disease protein

Rose, F., Hodak, M., & Bernholc, J. (2011) · Scientific Reports · doi:10.1038/srep00011 · Cited by 88 · see citing works

Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication

Flierl, A., Oliveira, L. M. A., Falomir‐Lockhart, L. J., Mak, S. K., Hesley, J., Soldner, F., Arndt‐Jovin, D. J., Jaenisch, R., Langston, J. W., Jovin, T. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112413 · Cited by 86 · see citing works

DNA induces folding in α-synuclein: Understanding the mechanism using chaperone property of osmolytes

Hegde, M. L., & Rao, K. S. J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.042 · Cited by 85 · see citing works

First Evidence for Helical Transitions in Supercoiled DNA by Amyloid β Peptide (1-42) and Aluminum: A New Insight in Understanding Alzheimer's Disease

Hegde, M. L., Anitha, S., Latha, K. S., Mustak, M. S., Stein, R., Ravid, R., & Rao, K. S. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:1-2:19 · Cited by 77 · see citing works

Studies on genomic DNA topology and stability in brain regions of Parkinson’s disease

Hegde, M. L., Gupta, V. B., Anitha, M., Harikrishna, T., Shankar, S. K., Muthane, U. B., Rao, K. S. J., & Rao, K. S. J. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.018 · Cited by 77 · see citing works

Site-Specific Copper-Catalyzed Oxidation of α-Synuclein: Tightening the Link between Metal Binding and Protein Oxidative Damage in Parkinson’s Disease

Miotto, M., Rodríguez, E. E., Valiente‐Gabioud, A. A., Monserrat, V. T., Binolfi, A., Quintanar, L., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2014) · Inorganic Chemistry · doi:10.1021/ic4031377 · Cited by 77 · see citing works

α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons

Ortega, R., Carmona, A., Roudeau, S., Perrin, L., Dučić, T., Carboni, E., Bohic, S., Cloetens, P., & Lingor, P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9146-x · Cited by 72 · see citing works

The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle

Ma, K., Song, L.-K., Yuan, Y., Zhang, Y., Han, N., Gao, K., & Chen, N. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.035 · Cited by 72 · see citing works

Thermodynamics imprinting reveals differential binding of metals to α-synuclein: Relevance to parkinson’s disease

..., B., & Rao, K. S. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.060 · Cited by 72 · see citing works

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease

Oczkowska, A., Kozubski, W. P., Lianeri, M., & Dorszewska, J. (2014) · Current Genomics · doi:10.2174/1389202914666131210205839 · Cited by 70 · see citing works

Oxidative stress induces nuclear translocation of C-terminus of α-synuclein in dopaminergic cells

Xu, S., Zhou, M., Yu, S., Cai, Y., Zhang, A., Uéda, K., & Chan, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.148 · Cited by 61 · see citing works

TRIM28 as a novel transcriptional elongation factor

Bunch, H., & Calderwood, S. K. (2015) · BMC Molecular Biology · doi:10.1186/s12867-015-0040-x · Cited by 60 · see citing works

Characterization of the action of Escherichia coli DNA polymerase I at incisions produced by repair endodeoxyribonucleases.

Mosbaugh, D. W., & Linn, S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68402-4 · Cited by 58 · see citing works

Upregulation of α‐synuclein by lipopolysaccharide and interleukin‐1 in human macrophages

Tanji, K., Mori, F., Imaizumi, T., Yoshida, H., Matsumiya, T., Tamo, W., Yoshimoto, M., Odagiri, H., Sasaki, M., Takahashi, H., et al. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01385.x · Cited by 55 · see citing works

The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome

Hegde, P. M., Dutta, A., Sengupta, S., Mitra, J., Adhikari, S., Tomkinson, A. E., Li, G., Boldogh, I. R., Hazra, T. K., MITRA, S. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642918 · Cited by 50 · see citing works

Analysis of Oxidative Damage by Gene‐Specific Quantitative PCR

Kovalenko, O. A., & Santos, J. H. (2009) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1901s62 · Cited by 49 · see citing works

New evidence on α-synuclein and Tau binding to conformation and sequence specific GCFNx01 rich DNA: Relevance to neurological disorders

Rao, K. S. J., Vasudevaraju, P., Guerrero, E. N., Hegde, M. L., Collen, T., & Britton, G. B. (2012) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.94811 · Cited by 48 · see citing works

NEIL2 protects against oxidative DNA damage induced by sidestream smoke in human cells

Sarker, A. H., Chatterjee, A., Williams, M., Lin, S., Havel, C., Jacob III, P., Boldogh, I., Hazra, T. K., Talbot, P., & Hang, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090261 · Cited by 44 · see citing works

Alpha-Synuclein Expression in the Developing Human Brain

Raghavan, R., de Kruijff, L., Sterrenburg, M. D., Rogers, B. B., Hladik, C. L., & White, C. L. (2004) · Pediatric and Developmental Pathology · doi:10.1007/s10024-003-7080-9 · Cited by 44 · see citing works

Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells

Qian, Y., Zheng, Y., Abraham, L., Ramos, K. S., & Tiffany‐Castiglioni, E. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.004 · Cited by 43 · see citing works

Potential of Neural Stem Cell-Based Therapy for Parkinson’s Disease

Chou, C.-H., Fan, H., & Hueng, D. (2015) · Parkinson s Disease · doi:10.1155/2015/571475 · Cited by 42 · see citing works

Accumulation of DNA Damage in Aging Neurons Occurs Through a Mechanism Other than Apoptosis

Mandavilli, B. S., & Rao, K. S. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041559.x · Cited by 37 · see citing works

Challenges and complexities of α-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson’s disease

Hegde, M. L., & Rao, K. S. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.015 · Cited by 36 · see citing works

Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats

Yasuhara, T., Hara, K., Sethi, K. D., Morgan, J. C., & Borlongan, C. V. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.072 · Cited by 35 · see citing works

Binding of Recombinant but Not Endogenous Prion Protein to DNA Causes DNA Internalization and Expression in Mammalian Cells

Yin, S., Fan, X., Yu, S., Li, C., & Sy, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800814200 · Cited by 26 · see citing works

Oxidative DNA Strand Scission Induced by Peptides

Prestwich, E. G., Roy, M. D., Rego, J., & Kelley, S. O. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.015 · Cited by 25 · see citing works

DNA damage preceding dopamine neuron degeneration in A53T human α-synuclein transgenic mice

Wang, D., Yu, T., Liu, Y., Yan, J., Guo, Y., Jing, Y., Yang, X., Song, Y., & Tian, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.008 · Cited by 24 · see citing works

Identification and characterization of a nuclear localization signal of TRIM28 that overlaps with the HP1 box

Moriyama, T., Sangel, P., Yamaguchi, H., Obuse, C., Miyamoto, Y., Oka, M., & Yoneda, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.108 · Cited by 19 · see citing works

Therapeutic applications of the TAT‐mediated protein transduction system for complex I deficiency and other mitochondrial diseases

Lin, B., & Kao, M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12858 · Cited by 11 · see citing works

Studies on the Mechanism of the DNA Nicking Property of Amyloid-β 40 : Implications in Alzheimer's Disease

Gupta, V. B., Monica, F. S., Berrocal, R., Rao, K. S., & Rao, K. S. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121249 · Cited by 5 · see citing works

The Unfolded Protein Response: Detecting and Responding to Fluctuations in the Protein-Folding Capacity of the Endoplasmic ReticulumPreprint

Karagöz, G. E., Acosta‐Alvear, D., & Walter, P. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033886 · Cited by 302 · see citing works

Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects

Mitra, J., Guerrero, E. N., Hegde, P. M., Liachko, N. F., Wang, H., Vasquez, V., Gao, J., Pandey, A., Taylor, J. P., Kraemer, B. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818415116 · Cited by 305 · see citing works

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders

Schaser, A. J., Osterberg, V. R., Dent, S. E., Stackhouse, T. L., Wakeham, C. M., Boutros, S. W., Weston, L. J., Owen, N., Weissman, T. A., Luna, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47227-z · Cited by 256 · see citing works

Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells

Tran, J., Anastacio, H. T. D., & Bardy, C. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0110-8 · Cited by 181 · see citing works

Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease

Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129 · see citing works

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease

Milanese, C., Cerri, S., Ulusoy, A., Gornati, S. V., Plat, A., Gabriels, S., Blandini, F., Di Monte, D. A., Hoeijmakers, J. H., & Mastroberardino, P. G. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0848-7 · Cited by 118 · see citing works

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders

Manzanza, N. D. O., Sedlackova, L., & Kalaria, R. N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690293 · Cited by 89 · see citing works

Review: Somatic mutations in neurodegeneration

Leija‐Salazar, M., Piette, C. E., & Proukakis, C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12465 · Cited by 84 · see citing works

Pervasive Genomic Damage in Experimental Intracerebral Hemorrhage: Therapeutic Potential of a Mechanistic-Based Carbon Nanoparticle

Dharmalingam, P., Talakatta, G., Mitra, J., Wang, H., Derry, P. J., Nilewski, L. G., McHugh, E. A., Fabian, R. H., Mendoza, K., Vasquez, V., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b05821 · Cited by 83 · see citing works

α-Synuclein Translocates to the Nucleus to Activate Retinoic-Acid-Dependent Gene Transcription

Davidi, D., Schechter, M., Elhadi, S. A., Matatov, A., Nathanson, L., & Sharon, R. (2020) · iScience · doi:10.1016/j.isci.2020.100910 · Cited by 81 · see citing works

DNA damage and repair in Parkinson's disease: Recent advances and new opportunities

González-Hunt, C. P., & Sanders, L. H. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24592 · Cited by 77 · see citing works

Cellular Protein Aggregates: Formation, Biological Effects, and Ways of Elimination

Wen, J.-H., He, X., Feng, Z.-S., Li, D.-Y., Tang, J., & Liu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108593 · Cited by 81 · see citing works

Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates

Elfarrash, S., Jensen, N. M., Ferreira, N., Betzer, C., Thevathasan, J. V., Diekmann, R., Adel, M., Omar, N. M., Boraie, M. Z., Gad, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0865-5 · Cited by 69 · see citing works

α-Synuclein in Parkinson's disease and advances in detection

Chen, R., Gu, X., & Wang, X. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.02.006 · Cited by 67 · see citing works

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies

Koss, D. J., Erskine, D., Porter, A., Palmoski, P., Menon, H., Todd, O., Leite, M., Attems, J., & Outeiro, T. F. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01403-x · Cited by 65 · see citing works

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences

Koziorowski, D., Figura, M., Milanowski, Ł., Szlufik, S., Alster, P., Madetko‐Alster, N., & Friedman, A. (2021) · Cells · doi:10.3390/cells10030656 · Cited by 59 · see citing works

Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs

Okonkwo, A., Mitra, J., Johnson, G. S., Li, L., Dashwood, W. M., Hegde, M. L., Chen, Y., Dashwood, R. H., & Rajendran, P. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800228 · Cited by 54 · see citing works

Somatic mutations in neurodegeneration: An update

Proukakis, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105021 · Cited by 53 · see citing works

The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration

Konopka, A., & Atkin, J. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.836885 · Cited by 51 · see citing works

Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes

Sison, S. L., Vermilyea, S., Emborg, M. E., & Ebert, A. D. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0893-8 · Cited by 46 · see citing works

Mechanisms of genotoxicity and proteotoxicity induced by the metalloids arsenic and antimony

Wysocki, R., Rodrigues, J. I., Litwin, I., & Tamás, M. J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04992-5 · Cited by 46 · see citing works

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future

Hu, M.-L., Pan, Y.-R., Yong, Y.-Y., Liu, Y., Yu, L., Qin, D.-L., Qiao, G., Law, B. Y.-K., Wu, J.-M., Zhou, X.-G., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102078 · Cited by 44 · see citing works

Genome instability and loss of protein homeostasis: converging paths to neurodegeneration?

Ainslie, A. P., Huiting, W., Barazzuol, L., & Bergink, S. (2021) · Open Biology · doi:10.1098/rsob.200296 · Cited by 40 · see citing works

Deficiency in classical nonhomologous end-joining–mediated repair of transcribed genes is linked to SCA3 pathogenesis

Chakraborty, A., Tapryal, N., Venkova, T., Mitra, J., Vasquez, V., Sarker, A. H., Duarte‐Silva, S., Huai, W., Ashizawa, T., Ghosh, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917280117 · Cited by 38 · see citing works

DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease

Wang, Z., Li, Y., Pu, J., & Zhang, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076313 · Cited by 39 · see citing works

A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson’s disease: Emerging concepts and challenges

Vasquez, V., Mitra, J., Wang, H., Hegde, P. M., Rao, K. S. J., & Hegde, M. L. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101729 · Cited by 38 · see citing works

Alpha‐Synuclein Modulates the Physical Properties of DNA

Jiang, K., Rocha, S., Westling, A., Sriram, K. K., Dorfman, K. D., Wittung-Stafshede, P. E., & Westerlund, F. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201803933 · Cited by 37 · see citing works

Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology

Avazzadeh, S., Baena-Montes, J. M., Keighron, C. N., Sánchez, Y. F., & Quinlan, L. R. (2021) · Brain Sciences · doi:10.3390/brainsci11030373 · Cited by 36 · see citing works

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron

Han, J., Fan, Y., Wu, P., Huang, Z., Li, X., Zhao, L., Ji, Y., & Zhu, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.743754 · Cited by 35 · see citing works

Crosstalk between Different DNA Repair Pathways Contributes to Neurodegenerative Diseases

Gupta, S., You, P., SenGupta, T., Nilsen, H. L., & Sharma, K. (2021) · Biology · doi:10.3390/biology10020163 · Cited by 34 · see citing works

Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties

Dent, S. E., King, D. P., Osterberg, V. R., Adams, E. K., Mackiewicz, M. R., Weissman, T. A., & Unni, V. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101552 · Cited by 30 · see citing works

Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models

Simmnacher, K., Lanfer, J., Rizo, T., Kaindl, J., & Winner, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00571 · Cited by 29 · see citing works

Human DNA polymerase η promotes RNA-templated error-free repair of DNA double-strand breaks

Chakraborty, A., Tapryal, N., Islam, A., Sarker, A. H., Kodavati, M. M., Mitra, J., Hegde, M. L., & Hazra, T. K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102991 · Cited by 29 · see citing works

From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein

Heras‐Garvin, A., & Stefanova, N. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.584536 · Cited by 29 · see citing works

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Vasquez, V., Kodavati, M. M., Mitra, J., Vedula, I., Hamilton, D. J., Garruto, R. M., Rao, K. S. J., & Hegde, M. L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07258-5 · Cited by 27 · see citing works

Novel Insights into Parkin–Mediated Mitochondrial Dysfunction and “Mito-Inflammation” in α-Synuclein Toxicity. The Role of the cGAS–STING Signalling Pathway

Gąssowska-Dobrowolska, M., Olech-Kochańczyk, G., Culmsee, C., & Adamczyk, A. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s468609 · Cited by 27 · see citing works

Progresses in both basic research and clinical trials of NAD+ in Parkinson’s disease

Maria Jose Perez, J., Baden, P., & Deleidi, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111499 · Cited by 25 · see citing works

Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study

Figura, M., Sitkiewicz, E., Świderska, B., Milanowski, Ł., Szlufik, S., Koziorowski, D., & Friedman, A. (2021) · Brain Sciences · doi:10.3390/brainsci11050661 · Cited by 24 · see citing works

A novel lncRNA Discn fine-tunes replication protein A (RPA) availability to promote genomic stability

Wang, L., Li, J., Zhou, H., Zhang, W., Gao, J. X., & Zheng, P. (2021) · Nature Communications · doi:10.1038/s41467-021-25827-6 · Cited by 24 · see citing works

DNA damage preceding dopamine neuron degeneration in A53T human α-synuclein transgenic mice

Wang, D., Yu, T., Liu, Y., Yan, J., Guo, Y., Jing, Y., Yang, X., Song, Y., & Tian, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.008 · Cited by 24 · see citing works

DNA damage and regulation of protein homeostasis

Paull, T. T. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103155 · Cited by 21 · see citing works

DNA repair deficiencies and neurodegeneration

Ropert, B., Gallrein, C., & Schumacher, B. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103679 · Cited by 21 · see citing works

Targeting α-synuclein post-translational modifications in Parkinson’s disease

Canever, J. B., Soares, E. S., de Avelar, N. C. P., & Cimarosti, H. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114204 · Cited by 21 · see citing works

Mitochondria - Nucleus communication in neurodegenerative disease. Who talks first, who talks louder?

Savu, D., & Moisoi, N. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148588 · Cited by 20 · see citing works

Decoding the Role of Familial Parkinson’s Disease-Related Genes in DNA Damage and Repair

Li, Y., Wang, Z., Ying, C.-Z., Zhang, B., & Pu, J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0216 · Cited by 18 · see citing works

Alpha-synuclein modulates the repair of genomic DNA double-strand breaks in a DNA-PKcs-regulated manner

Rose, E. P., Osterberg, V. R., Banga, J. S., Gorbunova, V. A., & Unni, V. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106675 · Cited by 18 · see citing works

An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson’s Disease1

Vasquez, V., Mitra, J., Perry, G. L., Rao, K. S. J., & Hegde, M. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180610 · Cited by 17 · see citing works

Transcriptional mutagenesis of α-synuclein caused by DNA oxidation in Parkinson’s disease pathogenesis

Basu, S., Song, M., Adams, L., Jeong, I., Je, G., Guhathakurta, S., Jiang, J. B., Boparai, N., Dai, W., Cardozo‐Pelaez, F., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02632-7 · Cited by 16 · see citing works

Introducing the Role of Genotoxicity in Neurodegenerative Diseases and Neuropsychiatric Disorders

Kisby, G. E., Wilson, D. M., & Spencer, P. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137221 · Cited by 16 · see citing works

Locked in a vicious cycle: the connection between genomic instability and a loss of protein homeostasis

Huiting, W., & Bergink, S. (2020) · Genome Instability & Disease · doi:10.1007/s42764-020-00027-6 · Cited by 17 · see citing works

α-synucleinopathy exerts sex-dimorphic effects on the multipurpose DNA repair/redox protein APE1 in mice and humans

Miner, K. M., Jamenis, A. S., Bhatia, T. N., Clark, R. N., Rajasundaram, D., Sauvaigo, S., Mason, D. M., Posimo, J. M., Abraham, N., DeMarco, B. A., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102307 · Cited by 15 · see citing works

Aggregated Alpha-Synuclein Inclusions within the Nucleus Predict Impending Neuronal Cell Death in a Mouse Model of Parkinsonism

Weston, L. J., Bowman, A. M., Osterberg, V. R., Meshul, C. K., Woltjer, R. L., & Unni, V. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315294 · Cited by 15 · see citing works

Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration

Du, T., Li, G., Zong, Q., Luo, H., Pan, Y., & Ma, K. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00429-0 · Cited by 14 · see citing works

Hemin-induced transient senescence via DNA damage response: a neuroprotective mechanism against ferroptosis in intracerebral hemorrhage

Malojirao, V. H., Vasquez, V., Kodavati, M., Mitra, J., Provasek, V., Voh, A. T. T., Liopo, A. V., Derry, P. J., Mikheev, A. M., Rostomily, R. C., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07983-3 · Cited by 13 · see citing works

C-terminal truncation of α -synuclein alters DNA structure from extension to compaction

Jiang, K., Rocha, S., Kumar, R., Westerlund, F., & Wittung-Stafshede, P. E. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.059 · Cited by 12 · see citing works

The role of DNA damage in neural stem cells ageing

Zhong, Y., Wang, G., Yang, S., Zhang, Y., & Wang, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31187 · Cited by 11 · see citing works

cGAS-STING activation in Parkinson’s Disease: From mechanisms to Disease-Modifying therapeutic strategies

Solomon, J., Mandal, S., & Aran, K. R. (2026) · Gene · doi:10.1016/j.gene.2026.150000 · Cited by 10 · see citing works

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models

Spathopoulou, A., Edenhofer, F., & Fellner, L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.786835 · Cited by 10 · see citing works

Biological Amyloids Chemically Damage DNA

Horváth, I., Aning, O. A., Sriram, K. K., Rehnberg, N., Chawla, S., Molin, M., Westerlund, F., & Wittung-Stafshede, P. E. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00461 · Cited by 9 · see citing works

Molecular chaperones in DNA repair mechanisms: Role in genomic instability and proteostasis in cancer

Hasan, A., Rizvi, S. F., Parveen, S., & Mir, S. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120852 · Cited by 9 · see citing works

Broken strands, broken minds: Exploring the nexus of DNA damage and neurodegeneration

Stavgiannoudaki, I., Goulielmaki, E., & Garinis, G. A. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103699 · Cited by 8 · see citing works

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodiesPreprint

Koss, D. J., Erskine, D., Porter, A., Palmoski, P., Leite, M., Attems, J., & Outeiro, T. F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.20.465125 · Cited by 8 · see citing works

Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway

Wu, Z., Xia, C., Zhang, C., Tang, D., Liu, F., Ou, Y., Gao, J., Yi, H., Yang, D., & Ma, K. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00425-w · Cited by 7 · see citing works

Cross-Linking and Covalent Labeling Mass Spectrometry Reveal Proteoform-Driven Conformational Changes in Alpha Synuclein

Dollar, A. N., & Webb, I. K. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05078 · Cited by 5 · see citing works

α-synuclein pathogenesis in hiPSC models of Parkinson’s disease

Baena-Montes, J. M., Avazzadeh, S., & Quinlan, L. R. (2021) · Neuronal Signaling · doi:10.1042/ns20210021 · Cited by 6 · see citing works

Nuclear Alpha‐Synuclein: Mechanisms and Implications for Synucleinopathies

Outeiro, T. F., & Koss, D. J. (2025) · Movement Disorders · doi:10.1002/mds.70138 · Cited by 5 · see citing works

A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies

Koss, D. J., Todd, O., Menon, H., Anderson, Z., Yang, T., Findlay, L., Graham, B., Palmowski, P., Porter, A., Morrice, N., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00813-4 · Cited by 7 · see citing works

Alteration of the Conformational Dynamics of a DNA Hairpin by α‐Synuclein in the Presence of Aqueous Two‐Phase Systems

Mukherjee, S., Knop, J., Möbitz, S., & Winter, R. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202002119 · Cited by 5 · see citing works

Global Effects of a PD Risk-SNP at the Alpha-Synuclein LocusPreprint

Prahl, J. D., Pierce, S. E., der Schans, E. J. C. V., Coetzee, G. A., & Tyson, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.06.451330 · Cited by 5 · see citing works

Lack of functional STING modulates immunity but does not protect dopaminergic neurons in the alpha-synuclein pre-formed fibrils Parkinson’s disease mouse model

Klæstrup, I. H., Reinert, L. S., Ferreira, S. A., Lauritsen, J., Toft, G. U., Gram, H., Jensen, P. H., Paludan, S. R., & Romero‐Ramos, M. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01228-0 · Cited by 5 · see citing works

Parkinson's disease

Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00001-0 · Cited by 3 · see citing works

Sgt1 Regulates α-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, PINK1 and PARK9

Bohush, A., Góral, A., Sierant, M., Nawrot, B., Leśniak, W., & Filipek, A. (2021) · Biomolecules · doi:10.3390/biom11111675 · Cited by 2 · see citing works

Protein–DNA interaction: One step closer to understanding the mechanism of neurodegeneration

Surguchov, A. P. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24346 · Cited by 2 · see citing works

Diverging Parkinson’s Disease Pathology between patient-derived GBA N370S , LRRK2 G2019S and engineered SNCA A53T iPSC-derived Dopaminergic NeuronsPreprint

Fathi, A., Bakshy, K., Zieghami, L., Fiene, R., Bradley, R., Dickerson, S., Carlson, C. B., Schachtele, S. J., & Liu, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.06.521264 · Cited by 2 · see citing works

Histone Post-Translational Modifications and DNA Double-Strand Break Repair in Neurodegenerative Diseases: An Epigenetic Perspective

Yeasmin, A., & Torrente, M. P. (2025) · Biology · doi:10.3390/biology14111556 · Cited by 1 · see citing works

Nucleophagy: The guardian of genome stability - from molecular mechanisms to disease associations

Chen, L., Feng, F., Zhou, Q., & Chen, L. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124270 · Cited by 1 · see citing works

Extrachromosomal DNA: Molecular perspectives in aging and neurodegenerative diseases

Ma, Y., Xia, Y., Karako, K., Song, P., & Hu, X. (2024) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2024.01058 · Cited by 1 · see citing works

Studies on curcumin-glucoside in the prevention of alpha-synuclein aggregation.

Emani, L. S., Rao, J. K., Jagadeesh Kumar, D., Pecchio, M., Lakey‐Beitia, J., Rodriguez, H., Cruz-Mora, J., Narayan, P., Anand, N., Mullur, G., et al. (2025) · PubMed Central · doi:10.1177/25424823251347260 · Cited by 1 · see citing works

The Role of TDP-43 in Genome Repair and beyond in Amyotrophic Lateral Sclerosis

Mitra, J., & Hegde, M. L. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92696 · Cited by 2 · see citing works

Post-mortem evidence for a reciprocal relationship between genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodiesPreprint

Koss, D. J., Todd, O., Menon, H., Anderson, Z., Yang, T., Attems, J., LeBeau, F. E. N., Erskine, D., & Outeiro, T. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.24.590825 · Cited by 1 · see citing works

Experimental Evidence for Phosphorylation-Driven Allosteric Regulation of Alpha Synuclein FunctionPreprint

Dollar, A. N., & Webb, I. K. (2025) · bioRxiv · doi:10.1101/2025.02.20.639338

Insulin resistance and Parkinson’s disease

Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00007-9

DNase2a downregulated by the cGAS-STING-IFN-MEF2C pathway prevents α-synuclein ubiquitination via NEDD4 in Parkinson's diseasePreprint

Zhang, J., Zhang, H., Li, L., Chen, F., Zhu, J., Cui, F., Sun, R., Ma, K., Zhao, Z., Chen, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7903266/v1

Additional file 1 of Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies

Koss, D. J., Erskine, D., Porter, A., Palmoski, P., Menon, H., Todd, O., Leite, M., Attems, J., & Outeiro, T. F. (2022) · Figshare · doi:10.6084/m9.figshare.20252738

Additional file 1 of Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration

Du, T., Li, G., Zong, Q., Luo, H., Pan, Y., & Ma, K. (2024) · Figshare · doi:10.6084/m9.figshare.26289104

Additional file 3 of Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies

Koss, D. J., Erskine, D., Porter, A., Palmoski, P., Menon, H., Todd, O., Leite, M., Attems, J., & Outeiro, T. F. (2022) · Figshare · doi:10.6084/m9.figshare.20252744

Additional file 4 of Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies

Koss, D. J., Erskine, D., Porter, A., Palmoski, P., Menon, H., Todd, O., Leite, M., Attems, J., & Outeiro, T. F. (2022) · Figshare · doi:10.6084/m9.figshare.20252747

Additional file 2 of Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies

Koss, D. J., Erskine, D., Porter, A., Palmoski, P., Menon, H., Todd, O., Leite, M., Attems, J., & Outeiro, T. F. (2022) · Figshare · doi:10.6084/m9.figshare.20252741

Parkinson’s disease linked LRRK2 G2019S drives oxidative nuclear DNA damage and PARP1 hyperactive signalingPreprint

Liu, J., González-Hunt, C. P., Richbourg, T., Barraza, I., Chen, C. G., Montes, C., Ma, L., Cao, R., Hanumaihgari, V., Gassman, N. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.27.708379

A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson’s disease: Emerging concepts and challenges

Vasquez, V., Mitra, J., Wang, H., Hegde, P. M., Rao, K. S. J., & Hegde, M. L. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101729 · Cited by 38 · see citing works

Environmental enrichment modulates depressive-like behavior and hippocampal neuroplasticity in the YAC128 mouse model of Huntington's disease

Brocardo, P. S., Plácido, E., Wink, A. C., Nascimento-Castro, C. D. P., Rodrigues, A. L. S., & Gil‐Mohapel, J. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.07.1500

Senescence and impaired DNA damage responses in alpha-synucleinopathy models

Yoon, Y.-S., You, J. S., Kim, T.-K., Ahn, W. J., Kim, M. J., Son, K. H., Ricarte, D., Ortiz, D. M., Lee, S., & Lee, H.-J. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00727-x · Cited by 63 · see citing works

Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson’s disease

Siddiqui, A., Chinta, S. J., Mallajosyula, J. K., Rajagopolan, S., Hanson, I. M., Rane, A., Melov, S., & Andersen, J. K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.024 · Cited by 182 · see citing works

α‐Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's disease

Hasegawa, T., Matsuzaki‐Kobayashi, M., Takeda, A., Sugeno, N., Kikuchi, A., Furukawa, K., Perry, G. L., Smith, M. A., & Itoyama, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.018 · Cited by 52 · see citing works